Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease [1]

Lancet

Volumn 348, Issue 9032, 1996, Pages 955-

  Will, R G ^a   Zeidler, M ^a   Brown, P ^a   Harrington, M ^a   Lee, K H ^a   Kenney, K L ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN;

CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOLOGY; HUMAN; IMMUNOASSAY; LETTER; PRIORITY JOURNAL;

EID: 0006921410     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)24040-1     Document Type: Letter

References (5)

1. RG Will JW Ironside M Zeidler A new variant of Creutzfeldt-Jakob disease in the UK Lancet 347 1996 921 925
2. G Hsish K Kenney CJ Gibbs The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies N Engl J Med 335 1996 924 930
3. CL Masters JO Harris DC Gajdusek Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering Ann Neurol 5 1979 177 188
4. H Budka A Aguzzi P Brown Tissue handling in suspected Creutzfeldt Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol 5 1995 319 322
5. M Shoji S Kawamoto Y Setoguchi The 14-3-3- protein as the antigen for lung cancer-associated human monoclonal antibody AE6F4 Hum Antibodies Hybridomas 5 1994 123 130